Product Information
FLECAINIDE ACETATE 150 MG TAB is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.2690 per EA under NDC 62559038201. Its NADAC has been published 557 times since Feb 3, 2016.
FDA first approved this application on Oct 28, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559038201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLECAINIDE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA075882FDA Approved
10/28/2002
TE Code
AB
On Market Since
12/28/2015
Pharmacological Classes
Price Statistics
The NADAC for FLECAINIDE ACETATE 150 MG TAB has been published 557 times since Feb 3, 2016, and over the history we have for it it has declined 61.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2690 per EA |
|---|---|
| All-time high | $0.8144 (Apr 13, 2016) |
| All-time low | $0.1778 (Nov 20, 2024) |
| 52-week high | $0.3088 |
| 52-week low | $0.2537 |
| Median price | $0.4694 |
| Average price | $0.4658 |
| Largest weekly change | -41.4% (Nov 20, 2024) |
| Weeks tracked | 557 |
| Tracking since | Feb 3, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Flecainide Acetate Tablet market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Flecainide Acetate Tablet market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiarrhythmic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLECAINIDE ACETATE 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for FLECAINIDE ACETATE 150 MG TAB, manufactured by ANI Pharmaceuticals, Inc., is $0.2690 per EA (NDC 62559038201), effective Sep 30, 2026.
How has the price of FLECAINIDE ACETATE 150 MG TAB changed over time?
Over the history we have for it, the NADAC for FLECAINIDE ACETATE 150 MG TAB has declined 61.7%. It has been tracked across 557 weekly CMS publications since Feb 3, 2016.
What are the highest and lowest recorded NADAC prices for FLECAINIDE ACETATE 150 MG TAB?
Since Feb 3, 2016, the NADAC for FLECAINIDE ACETATE 150 MG TAB has ranged from a low of $0.1778 (Nov 20, 2024) to a high of $0.8144 (Apr 13, 2016), with a median of $0.4694 per EA.
Are there cheaper alternatives to FLECAINIDE ACETATE 150 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of FLECAINIDE ACETATE 150 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FLECAINIDE ACETATE 150 MG TAB?
FLECAINIDE ACETATE 150 MG TAB (NDC 62559038201) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.